Geron Corp. (GERN)
1.505
-0.08
(-5.35%)
USD |
NASDAQ |
Sep 03, 16:00
1.505
0.00 (0.00%)
After-Hours: 20:00
Geron Research and Development Expense (TTM) : 73.89M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.89M |
| March 31, 2026 | 73.59M |
| December 31, 2025 | 73.72M |
| September 30, 2025 | 81.32M |
| June 30, 2025 | 80.40M |
| March 31, 2025 | 89.44M |
| December 31, 2024 | 103.74M |
| September 30, 2024 | 113.22M |
| June 30, 2024 | 122.49M |
| March 31, 2024 | 127.20M |
| December 31, 2023 | 125.05M |
| September 30, 2023 | 120.34M |
| June 30, 2023 | 115.52M |
| March 31, 2023 | 100.64M |
| December 31, 2022 | 95.52M |
| September 30, 2022 | 91.46M |
| June 30, 2022 | 85.38M |
| March 31, 2022 | 86.71M |
| December 31, 2021 | 85.73M |
| September 30, 2021 | 77.80M |
| June 30, 2021 | 72.89M |
| March 31, 2021 | 61.80M |
| December 31, 2020 | 51.49M |
| September 30, 2020 | 60.18M |
| June 30, 2020 | 57.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 56.97M |
| December 31, 2019 | 52.07M |
| September 30, 2019 | 32.23M |
| June 30, 2019 | 23.83M |
| March 31, 2019 | 16.90M |
| December 31, 2018 | 13.43M |
| September 30, 2018 | 10.87M |
| June 30, 2018 | 10.80M |
| March 31, 2018 | 10.10M |
| December 31, 2017 | 11.03M |
| September 30, 2017 | 12.63M |
| June 30, 2017 | 14.31M |
| March 31, 2017 | 16.39M |
| December 31, 2016 | 18.05M |
| September 30, 2016 | 17.91M |
| June 30, 2016 | 17.64M |
| March 31, 2016 | 17.88M |
| December 31, 2015 | 17.83M |
| September 30, 2015 | 18.20M |
| June 30, 2015 | 20.14M |
| March 31, 2015 | 20.48M |
| December 31, 2014 | 20.71M |
| September 30, 2014 | 21.44M |
| June 30, 2014 | 20.79M |
| March 31, 2014 | 20.44M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Precigen, Inc. | 31.01M |
| Editas Medicine, Inc. | 82.53M |
| Agenus, Inc. | 57.69M |
| Amgen, Inc. | 7.638B |
| Anika Therapeutics, Inc. | 27.45M |